10.28
2.07 (25.21%)
| Previous Close | 8.21 |
| Open | 9.41 |
| Volume | 5,616,094 |
| Avg. Volume (3M) | 575,300 |
| Market Cap | 292,189,120 |
| Price / Earnings (Forward) | 2.48 |
| Price / Sales | 12.29 |
| Price / Book | 1.36 |
| 52 Weeks Range |
| Profit Margin | -47.47% |
| Operating Margin (TTM) | -57.27% |
| Diluted EPS (TTM) | -2.52 |
| Quarterly Revenue Growth (YOY) | -22.70% |
| Total Debt/Equity (MRQ) | 18.25% |
| Current Ratio (MRQ) | 5.64 |
| Operating Cash Flow (TTM) | -89.33 M |
| Levered Free Cash Flow (TTM) | -53.72 M |
| Return on Assets (TTM) | -13.67% |
| Return on Equity (TTM) | -27.40% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Arcturus Therapeutics Holdings | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 7.89% |
| % Held by Institutions | 93.11% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |